MEDICAL CITY GREEN OAKS HOSPITAL
7808 CLODUS FIELDS DRIVE, DALLAS, TX · Medicalcityhealthcare · · NPI 1831140698
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Inj., eravacycline, 1 mg HCPCS J0122 | not published | not published | $1.21 – $1.21 | 1 |
| Inj, etelcalcetide, 0.1 mg HCPCS J0606 | not published | not published | $28.04 – $28.04 | 1 |
| Inj, eteplirsen, 10 mg HCPCS J1428 | not published | not published | $1,373.51 – $1,373.51 | 1 |
| Inj, evinacumab-dgnb, 5mg HCPCS J1305 | not published | not published | $186.31 – $186.31 | 1 |
| Inj., evomela, 1 mg HCPCS J9246 | not published | not published | $18.50 – $18.50 | 1 |
| Inj, factor x, (human), 1iu HCPCS J7175 | not published | not published | $9.53 – $62.59 | 2 |
| Inj, faricimab-svoa, 0.1mg HCPCS J2777 | not published | not published | $34.72 – $34.72 | 1 |
| Inj fe-based mr contrast,1ml HCPCS Q9953 | not published | not published | $443.89 – $443.89 | 1 |
| Inj. fe derisomaltose 10 mg HCPCS J1437 | not published | not published | $20.83 – $20.83 | 1 |
| Inj fensolvi 0.25 mg HCPCS J1951 | not published | not published | $134.26 – $134.26 | 1 |
| Inj ferric pyrophosphate cit HCPCS J1443 | not published | not published | $0.14 – $0.14 | 1 |
| Inj., fibryga, 1 mg HCPCS J7177 | not published | not published | $1.10 – $1.10 | 1 |
| Inj fluphenazine hcl 1.25 mg HCPCS J2679 | not published | not published | $7.15 – $7.15 | 1 |
| Inj, focinvez, 1mg HCPCS J1434 | not published | not published | $3.02 – $3.02 | 1 |
| Inj follitropin alfa 75 iu HCPCS S0126 | not published | not published | $432.37 – $432.37 | 1 |
| Inj follitropin beta 75 iu HCPCS S0128 | not published | not published | $410.62 – $410.62 | 1 |
| Inj for ext venography CPT 36005 | not published | not published | $1,889.01 – $1,889.01 | 1 |
| Inj for mammo ductogram CPT 19030 | not published | not published | $589.39 – $589.39 | 1 |
| Inj, fosaprepitant (teva) HCPCS J1456 | not published | not published | $1.21 – $1.21 | 1 |
| Inj fosnetupitant, palonoset HCPCS J1454 | not published | not published | $632.88 – $632.88 | 1 |
| Inj, fulvestrant (fresenius) HCPCS J9394 | not published | not published | $3.32 – $3.32 | 1 |
| Inj, gadopiclenol, 1 ml HCPCS A9573 | not published | not published | $3.47 – $3.47 | 1 |
| Inj ganirelix acetat 250 mcg HCPCS S0132 | not published | not published | $570.08 – $570.08 | 1 |
| Inj gemcitabine hcl (accord) HCPCS J9196 | not published | not published | $8.65 – $8.65 | 1 |
| Inj givosiran 0.5 mg HCPCS J0223 | not published | not published | $116.47 – $116.47 | 1 |
| Inj glofitamab gxbm, 2.5 mg HCPCS J9286 | not published | not published | $2,772.80 – $2,772.80 | 1 |
| Inj glycopyrrolate fres kabi HCPCS J1598 | not published | not published | $1.66 – $1.66 | 1 |
| Inj, granisetron, xr, 0.1 mg HCPCS J1627 | not published | not published | $5.29 – $25.61 | 2 |
| Inj., guselkumab, 1 mg HCPCS J1628 | not published | not published | $70.43 – $70.43 | 1 |
| Inj heparin, pfizer, 1000u HCPCS J1643 | not published | not published | $2.94 – $2.94 | 1 |
| Inj. herceptin hylecta, 10mg HCPCS J9356 | not published | not published | $62.92 – $62.92 | 1 |
| Inj herzuma 10 mg HCPCS Q5113 | not published | not published | $73.91 – $73.91 | 1 |
| Inj hrt cath w/s&i nonsel p-art angrp CPT 93568 | not published | not published | $664.29 – $664.29 | 1 |
| Inj hrt cath w/s&i sel hrt ang CPT 93563 | not published | not published | $418.63 – $418.63 | 1 |
| Inj hrt cath w/s&i sel hrt art CPT 93564 | not published | not published | $438.52 – $438.52 | 1 |
| Inj hrt cath w/s&i sel left vent CPT 93565 | not published | not published | $324.71 – $324.71 | 1 |
| Inj hrt cath w/s&i sel right vent CPT 93566 | not published | not published | $789.91 – $789.91 | 1 |
| Inj human fibrinogen con nos HCPCS J7178 | not published | not published | $1.48 – $7.30 | 2 |
| Inj hydroxyprogst capoat nos HCPCS J1729 | not published | not published | $132.27 – $132.27 | 1 |
| Inj., ibalizumab-uiyk, 10 mg HCPCS J1746 | not published | not published | $76.95 – $76.95 | 1 |
| Inj imip 4 cilas 4 releb 2mg HCPCS J0742 | not published | not published | $2.50 – $2.50 | 1 |
| Inj, imm glob bivigam, 500mg HCPCS J1556 | not published | not published | $77.30 – $504.48 | 2 |
| Inj, immphentiv, 20 mcg HCPCS J2373 | not published | not published | $0.14 – $0.14 | 1 |
| Inj. inebilizumab-cdon, 1 mg HCPCS J1823 | not published | not published | $484.40 – $484.40 | 1 |
| Inj intralesional <= 7 lsn(s) CPT 11900 | not published | not published | $169.11 – $169.11 | 1 |
| Inj intralesional > 7 lsns CPT 11901 | not published | not published | $147.37 – $147.37 | 1 |
| Inj, invega hafyera/trinza HCPCS J2427 | not published | not published | $12.67 – $12.67 | 1 |
| Inj ivig privigen 500 mg HCPCS J1459 | not published | not published | $49.18 – $283.50 | 2 |
| Inj, ixinity, 1 i.u HCPCS J7213 | not published | not published | $1.92 – $1.92 | 1 |
| Inj. jivi 1 iu HCPCS J7208 | not published | not published | $2.45 – $2.45 | 1 |
| Inj, kovaltry, 1 i.u HCPCS J7211 | not published | not published | $1.49 – $14.59 | 2 |
| Inj labetalol hcl hikma, 5mg HCPCS J1921 | not published | not published | $1.38 – $1.38 | 1 |
| Inj., lanadelumab-flyo, 1 mg HCPCS J0593 | not published | not published | $84.80 – $84.80 | 1 |
| Inj, lanreotide, (cipla) 1mg HCPCS J1932 | not published | not published | $25.42 – $25.42 | 1 |
| Inj, lecanemab-irmb, 1 mg HCPCS J0174 | not published | not published | $1.33 – $1.33 | 1 |
| Inj, lenacapavir, 1 mg HCPCS J1961 | not published | not published | $22.03 – $22.03 | 1 |
| Inj levocarnitine per 1 gm HCPCS J1955 | not published | not published | $24.38 – $211.18 | 2 |
| Inj levoleucovorin nos 0.5mg HCPCS J0641 | not published | not published | $0.02 – $1.72 | 2 |
| Inj, levothyroxine, freskabi HCPCS J0651 | not published | not published | $6.40 – $6.40 | 1 |
| Inj, levothyroxine, hikma HCPCS J0652 | not published | not published | $5.14 – $5.14 | 1 |
| Inj, linezolid (hospira) HCPCS J2021 | not published | not published | $6.34 – $6.34 | 1 |
| Inj. lumasiran, 0.5 mg HCPCS J0224 | not published | not published | $318.85 – $318.85 | 1 |
| Inj melpha hydroch nos 50 mg HCPCS J9245 | not published | not published | $157.10 – $5,828.83 | 2 |
| Inj melphalan (hepzato) 1 mg HCPCS J9248 | not published | not published | $773.80 – $773.80 | 1 |
| Inj menotropins 75 iu HCPCS S0122 | not published | not published | $379.29 – $379.29 | 1 |
| Inj mepivacaine hcl/10 ml HCPCS J0670 | not published | not published | $3.63 – $16.45 | 2 |
| Inj, meropenem (b. braun) HCPCS J2184 | not published | not published | $2.09 – $2.09 | 1 |
| Inj meropenem (wg crit care) HCPCS J2183 | not published | not published | $1.60 – $1.60 | 1 |
| Inj metaraminol bitartrate HCPCS J0380 | not published | not published | $10.23 – $10.23 | 1 |
| Inj, micafungin (par pharm) HCPCS J2247 | not published | not published | $0.31 – $0.31 | 1 |
| Inj, mirikizumab-mrkz, 1 mg HCPCS J2267 | not published | not published | $47.57 – $47.57 | 1 |
| Inj mogamulizumab-kpkc, 1 mg HCPCS J9204 | not published | not published | $243.63 – $243.63 | 1 |
| Inj, motixafortide, 0.25 mg HCPCS J2277 | not published | not published | $25.22 – $25.22 | 1 |
| Inj, moxifloxacin 100 mg HCPCS J2280 | not published | not published | $8.57 – $72.40 | 2 |
| Inj moxifloxacin (fres kabi) HCPCS J2281 | not published | not published | $7.10 – $7.10 | 1 |
| Inj multihance HCPCS A9577 | not published | not published | $1.82 – $14.59 | 2 |
| Inj multihance multipack HCPCS A9578 | not published | not published | $1.81 – $14.02 | 2 |
| Inj. mycophenolate mofetil HCPCS J7519 | not published | not published | $0.31 – $0.31 | 1 |
| Inj naloxone hydrochloride HCPCS J2310 | not published | not published | $9.21 – $164.75 | 2 |
| Inj. naxitamab-gqgk, 1 mg HCPCS J9348 | not published | not published | $641.83 – $641.83 | 1 |
| Inj nephrosto/ureterogram w/img exstng access CPT 50431 | not published | not published | $659.50 – $659.50 | 1 |
| Inj, nogapendekin pmln, 1mcg HCPCS J9028 | not published | not published | $94.58 – $94.58 | 1 |
| Inj non-compmd foam sclrsnt mlt trncl veins same leg CPT 36466 | not published | not published | $10,324.36 – $10,324.36 | 1 |
| Inj non-compmd foam sclrsnt sgl trncl vein CPT 36465 | not published | not published | $10,063.54 – $10,063.54 | 1 |
| Inj ocrelizumab 1mg hya-ocsq HCPCS J2351 | not published | not published | $45.19 – $45.19 | 1 |
| Inj, ocriplasmin, 0.125 mg HCPCS J7316 | not published | not published | $5,982.93 – $5,982.93 | 1 |
| Inj octafluoropropane mic,ml HCPCS Q9956 | not published | not published | $41.88 – $232.28 | 2 |
| Inj ogivri 10 mg HCPCS Q5114 | not published | not published | $46.82 – $46.82 | 1 |
| Inj, olaratumab, 10 mg HCPCS J9285 | not published | not published | $365.12 – $365.12 | 1 |
| Inj olipudase alfa-rpcp 1mg HCPCS J0218 | not published | not published | $381.24 – $381.24 | 1 |
| Inj, omacetaxine mep, 0.01mg HCPCS J9262 | not published | not published | $17.88 – $17.88 | 1 |
| Inj., omadacycline, 1 mg HCPCS J0121 | not published | not published | $3.87 – $3.87 | 1 |
| Inj ontruzant 10 mg HCPCS Q5112 | not published | not published | $28.74 – $28.74 | 1 |
| Inj, palonosetron (posfrea) HCPCS J2468 | not published | not published | $59.91 – $59.91 | 1 |
| Inj, panzyga, 500 mg HCPCS J1576 | not published | not published | $70.43 – $70.43 | 1 |
| Inj, pasireotide long acting HCPCS J2502 | not published | not published | $526.94 – $2,256.35 | 2 |
| Inj., patisiran, 0.1 mg HCPCS J0222 | not published | not published | $99.04 – $99.04 | 1 |
| Inj, pegcetacoplan, 1mg HCPCS J2781 | not published | not published | $143.99 – $143.99 | 1 |
| Inj pegfilgrastim-bmez 0.5mg HCPCS Q5120 | not published | not published | $24.71 – $24.71 | 1 |
| Inj. pemetrexed, 10 mg HCPCS J9304 | not published | not published | $46.35 – $46.35 | 1 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.